UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Cell demise inhibited: Unexpected liaisons between mitochondria and IκΒα

Molecular & cellular oncology, 2021, Vol.8 (6), p.995020-995020

Pazarentzos, Evangelos

2021

Link zum Volltext

Verfügbarkeit prüfen

Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction

The EMBO journal, 2011-02, Vol.30 (3), p.556-568

2011

Link zum Volltext

Verfügbarkeit prüfen

NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer

Cell reports (Cambridge), 2015-04, Vol.11 (1), p.98-110

2015

Link zum Volltext

Verfügbarkeit prüfen

Synthetic Essentiality of Metabolic Regulator PDHK1 in PTEN-Deficient Cells and Cancers

Cell reports (Cambridge), 2019-08, Vol.28 (9), p.2317-2330.e8

2019

Link zum Volltext

Verfügbarkeit prüfen

Adaptive stress signaling in targeted therapy resistance in cancer

Oncogene, 2015-02, Vol.34 (45), p.5599-5606

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1713: PDK1 and hexokinase 2 are downstream effectors of PTEN loss and regulate response to targeted therapies in multiple tumor types

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1713-1713

2014

Link zum Volltext

Verfügbarkeit prüfen

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer

Nature medicine, 2015-09, Vol.21 (9), p.1038-1047

2015

Link zum Volltext

Verfügbarkeit prüfen

Specific disintegration of complex II succinate:ubiquinone oxidoreductase links pH changes to oxidative stress for apoptosis induction

Cell death and differentiation, 2011-02, Vol.18 (2), p.338-349

2011

Link zum Volltext

Verfügbarkeit prüfen

The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood–brain barrier in vitro

Brain research, 2016-10, Vol.1648 (Pt A), p.232-242

2016

Link zum Volltext

Verfügbarkeit prüfen

Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution

Scientific reports, 2017-03, Vol.7 (1), p.44206-44206, Article 44206

2017

Link zum Volltext

Verfügbarkeit prüfen

The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) with the human blood–brain barrier in vitro

Brain research, 2016

2016

Link zum Volltext

Verfügbarkeit prüfen

CKMT1 regulates the mitochondrial permeability transition pore in a process that provides evidence for alternative forms of the complex

Journal of cell science, 2014-04, Vol.127 (Pt 8), p.1816-1828

2014

Link zum Volltext

Verfügbarkeit prüfen

De-ubiquitinating proteases USP2a and USP2c cause apoptosis by stabilising RIP1

Biochimica et biophysica acta, 2012-08, Vol.1823 (8), p.1353-1365

2012

Link zum Volltext

Verfügbarkeit prüfen

Dose-dependent Neuroprotection of VEGF165 in Huntington's Disease Striatum

Molecular therapy, 2013-10, Vol.21 (10), p.1862-1875

2013

Link zum Volltext

Verfügbarkeit prüfen

IκΒα inhibits apoptosis at the outer mitochondrial membrane independently of NF-κB retention

The EMBO journal, 2014-12, Vol.33 (23), p.2814-2828

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1836: Erlotinib induces NF-kappa B dependence that promotes EGFR tyrosine kinase inhibitor resistance in lung adenocarcinoma

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1836-1836

2014

Link zum Volltext

Verfügbarkeit prüfen

I[kappa][Beta][alpha] inhibits apoptosis at the outer mitochondrial membrane independently of NF-[kappa]B retention

The EMBO journal, 2014-12, Vol.33 (23), p.2814

2014

Link zum Volltext

Verfügbarkeit prüfen

Anticancer gene transfer for cancer gene therapy

Advances in experimental medicine and biology, 2014, Vol.818, p.255

2014

Link zum Volltext

Verfügbarkeit prüfen

Dose-dependent Neuroprotection of VEGF sub(165) in Huntington's Disease Striatum

Molecular therapy, 2013-10, Vol.21 (10), p.1862-1875

2013

Link zum Volltext

Verfügbarkeit prüfen

Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction: Fis1 induces apoptosis via Bap31

The EMBO journal, 2011-02, Vol.30 (3), p.556-568

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-239: The Hippo effector YAP promotes resistance to RAF and MEK targeted therapies

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.LB-239-LB-239

2015

Link zum Volltext

Verfügbarkeit prüfen

IκBα inhibits apoptosis at the outer mitochondrial membrane through a novel, NF-κB-independent, interaction with VDAC1

Pazarentzos, Evangelos

2012

Link zum Volltext
ProQuest

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(20)

Publikationsform

Sprache

Englisch
(24)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cell demise inhibited: Unexpected liaisons between mitochondria and IκΒα

Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer

Synthetic Essentiality of Metabolic Regulator PDHK1 in PTEN-Deficient Cells and Cancers

Adaptive stress signaling in targeted therapy resistance in cancer

Abstract 1713: PDK1 and hexokinase 2 are downstream effectors of PTEN loss and regulate response to targeted therapies in multiple tumor types

AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer

Specific disintegration of complex II succinate:ubiquinone oxidoreductase links pH changes to oxidative stress for apoptosis induction

The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood–brain barrier in vitro

Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution

The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) with the human blood–brain barrier in vitro

CKMT1 regulates the mitochondrial permeability transition pore in a process that provides evidence for alternative forms of the complex

De-ubiquitinating proteases USP2a and USP2c cause apoptosis by stabilising RIP1

Dose-dependent Neuroprotection of VEGF165 in Huntington's Disease Striatum

IκΒα inhibits apoptosis at the outer mitochondrial membrane independently of NF-κB retention

Abstract 1836: Erlotinib induces NF-kappa B dependence that promotes EGFR tyrosine kinase inhibitor resistance in lung adenocarcinoma

I[kappa][Beta][alpha] inhibits apoptosis at the outer mitochondrial membrane independently of NF-[kappa]B retention

Anticancer gene transfer for cancer gene therapy

Dose-dependent Neuroprotection of VEGF sub(165) in Huntington's Disease Striatum

Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction: Fis1 induces apoptosis via Bap31

Abstract LB-239: The Hippo effector YAP promotes resistance to RAF and MEK targeted therapies

IκBα inhibits apoptosis at the outer mitochondrial membrane through a novel, NF-κB-independent, interaction with VDAC1

Suchergebnisse filtern